Skip to main content

Table 1 Adequate organ function laboratory values

From: PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer

System

Laboratory Value

Hematological

 Absolute leukocyte count

≥2500 /mcL

 Absolute lymphocyte count (ALC)

≥500 /mcL

 Absolute neutrophil count (ANC)

≥1500 /mcL

 Platelets

≥100,000 / mcL

 Hemoglobin

≥9 g/dL or ≥ 5.6 mmol/L without transfusion or EPO dependency (within 7 days of assessment)

Renal

 Serum creatinine

≤1.5 X upper limit of normal (ULN)

 OR

OR

 Measured or calculateda creatinine clearance

(GFR can also be used in place of creatinine or CrCl)

≥60 mL/min for subject with creatinine levels > 1.5 X institutional ULN

Hepatic

 Serum total bilirubin

≤ 1.5 X ULN

 OR

OR

 Direct bilirubin

≤ ULN for subjects with total bilirubin levels > 1.5 ULN

 AST (SGOT) and ALT (SGPT)

≤ 2.5 X ULN OR

≤ 5 X ULN for subjects with liver metastases

 Albumin

> 2.5 mg/dL

Coagulation

 International Normalized Ratio (INR) or Prothrombin Time (PT)

≤1.5 X ULN unless subject is receiving anticoagulant therapyas long as PT or PTT is within therapeutic range of intended use of anticoagulants

 Activated Partial Thromboplastin Time (aPTT)

≤1.5 X ULN unless subject is receiving anticoagulant therapy

as long as PT or PTT is within therapeutic range of intended use of anticoagulants

  1. aCreatinine clearance should be calculated per institutional standard